当前位置: X-MOL 学术Clin. Gastroenterol. Hepatol. › 论文详情
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.
Clinical Gastroenterology and Hepatology ( IF 7.958 ) Pub Date : 2019-04-19 , DOI: 10.1016/j.cgh.2019.04.037
Maribeth R Nicholson,Paul D Mitchell,Erin Alexander,Sonia Ballal,Mark Bartlett,Penny Becker,Zev Davidovics,Michael Docktor,Michael Dole,Grace Felix,Jonathan Gisser,Suchitra K Hourigan,M Kyle Jensen,Jess L Kaplan,Judith Kelsen,Melissa Kennedy,Sahil Khanna,Elizabeth Knackstedt,McKenzie Leier,Jeffery Lewis,Ashley Lodarek,Sonia Michail,Maria Oliva-Hemker,Tiffany Patton,Karen Queliza,George H Russell,Namita Singh,Aliza Solomon,David L Suskind,Steven Werlin,Richard Kellermayer,Stacy A Kahn

BACKGROUND & AIMS Fecal microbiota transplantation (FMT) is commonly used to treat Clostridium difficile infection (CDI). CDI is an increasing cause of diarrheal illness in pediatric patients, but the effects of FMT have not been well studied in children. We performed a multi-center retrospective cohort study of pediatric and young adult patients to evaluate the efficacy, safety, and factors associated with a successful FMT for the treatment of CDI. METHODS We performed a retrospective study of 372 patients, 11 months to 23 years old, who underwent FMT at 18 pediatric centers, from February 1, 2004, to February 28, 2017; 2-month outcome data were available from 335 patients. Successful FMT was defined as no recurrence of CDI in the 2 months following FMT. We performed stepwise logistic regression to identify factors associated with successful FMT. RESULTS Of 335 patients who underwent FMT and were followed for 2 months or more, 271 (81%) had a successful outcome following a single FMT and 86.6% had a successful outcome following a first or repeated FMT. Patients who received FMT with fresh donor stool (odds ratio [OR], 2.66; 95% CI, 1.39-5.08), underwent FMT via colonoscopy (OR, 2.41; 95% CI, 1.26-4.61), did not have a feeding tube (OR, 2.08; 95% CI, 1.05-4.11), or had 1 less episode of CDI before FMT (OR, 1.20; 95% CI, 1.04-1.39) had increased odds for successful FMT. Seventeen patients (4.7%) had a severe adverse event during the 3-month follow-up period, including 10 hospitalizations. CONCLUSIONS Based on the findings from a large multi-center retrospective cohort, FMT is effective and safe for the treatment of CDI in children and young adults. Further studies are required to optimize the timing and method of FMT for pediatric patients-factors associated with success differ from those of adult patients.
更新日期:2020-02-20

 

全部期刊列表>>
全球疫情及响应:BMC Medicine专题征稿
欢迎探索2019年最具下载量的化学论文
新版X-MOL期刊搜索和高级搜索功能介绍
化学材料学全球高引用
ACS材料视界
南方科技大学
x-mol收录
南方科技大学
自然科研论文编辑服务
上海交通大学彭文杰
中国科学院长春应化所于聪-4-8
武汉工程大学
课题组网站
X-MOL
深圳大学二维材料实验室张晗
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug